cobaltiprotoporphyrin has been researched along with Diabetic Glomerulosclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abo El Gheit, R; Emam, MN | 1 |
Baban, B; Elmarakby, AA; Faulkner, J; Saleh, MA; Sullivan, JC | 1 |
2 other study(ies) available for cobaltiprotoporphyrin and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Targeting heme oxygenase-1 in early diabetic nephropathy in streptozotocin-induced diabetic rats.
Topics: Animals; Biomarkers; Blood Glucose; Chemokine CCL2; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Induction; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Hydroxyproline; Insulin; Intercellular Adhesion Molecule-1; Kidney; Male; Molecular Targeted Therapy; NADPH Oxidases; NF-kappa B; Protoporphyrins; Rats; Streptozocin; Tumor Necrosis Factor-alpha | 2016 |
Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats.
Topics: Animals; Apoptosis; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Evaluation, Preclinical; Heme Oxygenase-1; Hypertension; Inflammation; Kidney Glomerulus; Male; Nephrosclerosis; Oxidative Stress; Permeability; Proteinuria; Protoporphyrins; Random Allocation; Rats; Rats, Inbred SHR | 2012 |